Table 3: Baseline characteristics and probability of ART survival during 5-year of follow-up (Kaplan-Meier method) of HIV patients receiving ART, Hawassa University Comprehensive specialized Hospital, Sidama, Ethiopia from January 2015 to December 2019 (n = 483).
|
Characteristics (Variables) |
Mean survival time/Probability in month over 5 yr (95% CI)
|
Log rank test |
P-value
|
|
Age in years [mean = 32.8, SD = 12.8] 18-39 40-59 > = 60 |
58.89 (57.95, 59.85) 56.68 (55.01, 58.36) 42.99 (37.68, 48.31) |
141 |
p ≤ 0.001 |
|
WHO clinical stage I & II III & IV |
58.97 (58.11, 59.84) 51.61 (49.50, 53.72) |
40 |
p ≤ 0.01 |
|
CD4 cell count(Cells/µL) < = 200 > 200 |
51.81 (48.41, 55.22) 54.95 (52.32, 57.59) 39.85 (35.43, 44.26) |
29.5 |
p ≤ 0.001 |
|
Functional status Working Ambulatory Bed ridden |
58.37 (57.62, 59.11) 57.34 (55.43, 59.26) 55.52 (41.14, 49.91) |
120 |
p ≤ 0.001 |
|
HIV/TB co-infection Yes No |
54.69 (52.01, 57.38) 57.88 (56.79, 58.97) |
6.10 |
p ≤ 0.01 |
|
Hemoglobin > = 11 g/dl (Normal) < 11 g/dl (Anemia) |
57.94 (56.86, 59.01) 55.11 (52.99, 57.23) |
8.32 |
p ≤ 0.01 |